KP Tissue Inc.
KPTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $830 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$752 | -$321 |
| Operating Expenses | $0 | $830 | -$752 | -$321 |
| Operating Income | $0 | $0 | $1,504 | $0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,489 | -$830 | -$14,051 | $1,121 |
| Pre-Tax Income | $2,489 | -$830 | -$12,547 | $1,121 |
| Tax Expense | $56 | $4,107 | -$2,298 | -$118 |
| Net Income | $2,433 | -$5 | -$10,249 | $1,239 |
| % Margin | – | – | – | – |
| EPS | 0.24 | -0.5 | -1.03 | 0.13 |
| % Growth | 148% | 51.5% | -892.3% | – |
| EPS Diluted | 0.24 | -0.5 | -1.03 | 0.13 |
| Weighted Avg Shares Out | 9,976 | 9,955 | 9,936 | 9,835 |
| Weighted Avg Shares Out Dil | 9,977 | 9,956 | 9,936 | 9,836 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $11,795 | $0 |
| Depreciation & Amortization | $264,783 | $239 | $115,239 | $0 |
| EBITDA | $264,783 | $239 | $115,991 | -$321 |
| % Margin | – | – | – | – |